Product Information
ADVAIR HFA 115-21 MCG INHALER is a brand product labeled by GlaxoSmithKline LLC, priced at $18.7795 per GM under NDC 00173071622. Its NADAC has been published 527 times since Nov 28, 2013.
FDA first approved this application on Jun 8, 2006.
Strength
115; 21 ug/1; ug/1
Manufacturer
GlaxoSmithKline LLCNDC
00173071622
Classification
Brand
Dosage Form
AEROSOL, METERED
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATEApproval Type
New Drug (NDA)
FDA Application
NDA021254FDA Approved
6/8/2006
On Market Since
9/29/2008
Pharmacological Classes
Price Statistics
The NADAC for ADVAIR HFA 115-21 MCG INHALER has been published 527 times since Nov 28, 2013, and over the history we have for it it has risen 7.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.7795 per GM |
|---|---|
| All-time high | $26.3818 (Jun 15, 2022) |
| All-time low | $17.4778 (Nov 28, 2013) |
| 52-week high | $18.7795 |
| 52-week low | $18.6826 |
| Median price | $21.7865 |
| Average price | $22.0527 |
| Largest weekly change | -29.0% (Apr 17, 2024) |
| Weeks tracked | 527 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ADVAIR HFA 115-21 MCG INHALER?
The current National Average Drug Acquisition Cost (NADAC) for ADVAIR HFA 115-21 MCG INHALER, manufactured by GlaxoSmithKline LLC, is $18.7795 per GM (NDC 00173071622), effective Aug 19, 2026.
How has the price of ADVAIR HFA 115-21 MCG INHALER changed over time?
Over the history we have for it, the NADAC for ADVAIR HFA 115-21 MCG INHALER has risen 7.4%. It has been tracked across 527 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ADVAIR HFA 115-21 MCG INHALER?
Since Nov 28, 2013, the NADAC for ADVAIR HFA 115-21 MCG INHALER has ranged from a low of $17.4778 (Nov 28, 2013) to a high of $26.3818 (Jun 15, 2022), with a median of $21.7865 per GM.
Are there cheaper alternatives to ADVAIR HFA 115-21 MCG INHALER?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ADVAIR HFA 115-21 MCG INHALER in a comparable dosage form, but none are currently priced below it.
Who manufactures ADVAIR HFA 115-21 MCG INHALER?
ADVAIR HFA 115-21 MCG INHALER (NDC 00173071622) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.